Journal
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
Volume 181, Issue -, Pages -Publisher
ELSEVIER
DOI: 10.1016/j.ejps.2022.106366
Keywords
Biomimetic(s); In vitro model(s); Oral absorption; Permeability; Prodrug(s); Supersaturation
Categories
Ask authors/readers for more resources
Fosamprenavir is a phosphate ester prodrug that can be converted into the parent drug amprenavir. A novel in vitro setup was designed to monitor the dissolution/bioconversion/permeation process of fosamprenavir. The setup consisted of diffusion cells with a biomimetic barrier, and microdialysis sampling was used to follow the enzymatic conversion in real-time. The results showed supersaturation of amprenavir and increased flux across the biomimetic barrier.
Fosamprenavir is a phosphate ester prodrug that, upon dissolution, is cleaved to the poorly soluble yet readily absorbable parent drug amprenavir. In this study, a novel cell-free in vitro setup with quasi-continuous monitoring of the dynamic dissolution/bio-conversion/permeation of fosamprenavir was designed and tested. It consists of side-by-side diffusion cells, where the donor and acceptor compartments are separated by the biomimetic barrier PermeaPad (R), and sampling from the donor compartment is accomplished via a microdialysis probe. Externally added bovine alkaline phosphatase induced bioconversion in the donor compartment. Microdialysis sampling allowed to follow the enzymatic conversion of fosamprenavir to amprenavir by the bovine alkaline phosphatase in an (almost) real-time manner eliminating the need to remove or inactivate the enzyme.Biomimetic conversion rates in the setup were established by adding appropriate amounts of the alkaline phosphatase. A substantial (6.5-fold) and persistent supersaturation of amprenavir was observed due to bioconversion at lower (500 mu M) concentrations, resulting in a substantially increased flux across the biomimetic barrier, nicely reflecting the situation in vivo. At conditions with an almost 10-fold higher dose than the usual human dose, some replicates showed premature precipitation and collapse of supersaturation, while others did not. In conclusion, the proposed novel tool appears very promising in gaining an in-depth mechanistic understanding of the bioconversion/permeation interplay, including transient supersaturation of phosphate-ester prodrugs like fosamprenavir.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available